New Key Statistics Module, Z-Score and F-Score
NAS:SRRA Key Ratios
Market Cap $ M | 1,342.82 |
Enterprise Value $ M | 1,074.42 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 5.00 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -6.77 |
Beneish M-Score | -2.36 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 37.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.47 |
EV-to-EBITDA | -10.50 |
PEG | -- |
Shares Outstanding M | 24.42 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 21.27 |
Current Ratio | 21.27 |
ROA % (ttm) | -73.49 |
ROE % (ttm) | -80.40 |
ROIC % (ttm) | -1,767.31 |
Dividend Yield % | -- |
Altman Z-Score | -- |
SRRA Number of Guru Trades
SRRA Volume of Guru Trades
Gurus Latest Trades with NAS:SRRA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SRRA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sierra Oncology Inc Insider Transactions
No Available Data
News about NAS:SRRA
Total 0- 1